In one study, Tseng et al. [7] found that 62% of adenocarcinomas (ACs) were in the upper lobes and that mutations of the epidermal growth factor receptor (EGFR) gene were more frequent in ACs in the upper lobes. This evidence concerns the gene EGFR and adenocarcinoma.